Compounds > l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine
Page last updated: 2024-09-03

l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Colonic Neoplasms

l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine has been researched along with Colonic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morishima, H; Naito, K; Nishimura, S; Okuyama, A; Suda, H; Tanaka, N1
Akiyama, T; Nakajima, M; Okuyama, A1

Reviews

1 review(s) available for l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Colonic Neoplasms

ArticleYear
[CDK and MMP inhibitors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:11

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Colonic Neoplasms; Cyclin-Dependent Kinases; Dipeptides; Doxorubicin; Enzyme Inhibitors; Fibrosarcoma; Humans; Metalloendopeptidases; Mice; Mice, Nude; Protease Inhibitors; Succinates

1997

Other Studies

1 other study(ies) available for l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Colonic Neoplasms

ArticleYear
Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor.
    Annals of the New York Academy of Sciences, 1994, Sep-06, Volume: 732

    Topics: Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Dipeptides; Humans; Lung Neoplasms; Metalloendopeptidases; Mice; Mice, Nude; Succinates; Transplantation, Heterologous

1994